U.S. RESEARCH ROUNDUP- Allovir, Facebook, Vertex

Fiesta Restaurant

24/08/2020 08:01

Aug 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Allovir, Facebook and Vertex on Monday. 
    
    HIGHLIGHTS
     * Allovir Inc  ALVR.O : JP Morgan starts with overweight rating; target price $50
     * Facebook Inc  FB.O : Jefferies raises target price to $310 from $300
     * Vertex Inc  VERX.O : Jefferies starts with buy rating; target price $34
        
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
    
     * Allovir Inc  ALVR.O : JP Morgan starts with overweight rating; target price $50
     * ASGN Inc  ASGN.N : Jefferies raises target price to $72 from $54
     * Brighthouse Financial Inc  BHF.O : Evercore ISI raises target price to $44 from $40
     * Deere & Co  DE.N : RBC raises target price to $228 from $180
     * Dick's Sporting Goods Inc  DKS.N : JP Morgan raises target price to $52 from $41
     * Facebook Inc  FB.O : Jefferies raises target price to $310 from $300
     * Fiesta Restaurant Group Inc  FRGI.O : Piper Sandler raises target price to $10 from $8
     * Howard Hughes Corp  HHC.N : Jefferies raises target price to $82 from $80
     * IRhythm Technologies Inc  IRTC.O : JP Morgan raises target price to $235 from $140
     * Lululemon Athletica Inc  LULU.O : Susquehanna raises target price to $426 from $360
     * Principal Financial Group Inc  PFG.O : Credit Suisse raises target price to $46 from $43
     * Vertex Inc  VERX.O : Jefferies starts with buy rating; target price $34
     * Williams-Sonoma Inc  WSM.N : JP Morgan raises target price to $89 from $75
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))